{
  "meta": {
    "title": "Infant_Of_Diabetic_Mother",
    "url": "https://brainandscalpel.vercel.app/infant-of-diabetic-mother-85fd3ca1.html",
    "scrapedAt": "2025-11-29T18:33:16.778Z"
  },
  "questions": [
    {
      "id": 15156,
      "choices": [
        {
          "id": 60584,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital dislocated hip</span></span></p>"
        },
        {
          "id": 60585,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dacryostenosis</span></span></p>"
        },
        {
          "id": 60586,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyaline membrane disease</span></span></p>"
        },
        {
          "id": 60587,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperglycemia</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 35-week-gestation infant, born to a mother with poorly controlled pregestational diabetes (insulin-dependent with vascular disease, HbA1C 9%), is delivered via cesarean section due to fetal macrosomia and distress. Neonate is at risk for several complications due to the maternal diabetes and premature birth. </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In addition to birth asphyxia, cardiac septal hypertrophy, and polycythemia, which of the following conditions is this infant at an increased risk for?</span></span></span></p>",
      "unique_key": "Q3201735",
      "question_audio": null,
      "question_video": null,
      "map_id": 32629,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hyaline membrane disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Infants born to mothers </strong>with <strong>poorly controlled diabetes </strong>are at risk for <strong>respiratory distress syndrome (surfactant deficiency)</strong> at <strong>later gestational ages </strong>than seen in <strong>infants born </strong>to <strong>mothers </strong>who <strong>do not have diabetes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Infants of diabetic mothers </strong>are also at <strong>increased risk of the following complications:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caudal regression syndrome</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Macrosomia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Congenital heart diseases</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polycythemia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prematurity</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Congenital dislocated hip </strong>is <strong>not </strong>specifically <strong>associated with maternal diabetes </strong>or prematurity but is related to factors like breech presentation and family history.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Dacryostenosis</strong>, or the <strong>obstruction of the nasolacrimal duct</strong>, is a <strong>common condition in newborns </strong>but is not directly linked to maternal diabetes or prematurity.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Hyperglycemia is less common in infants </strong>of <strong>diabetic mothers </strong>immediately <strong>postpartum</strong>. These infants are typically at risk for hypoglycemia due to their own increased insulin production in response to maternal hyperglycemia before birth.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Hyaline membrane disease</strong>, also known as <strong>neonatal respiratory distress syndrome</strong>, is more <strong>common in preterm infants </strong>due to <strong>insufficient surfactant production</strong>. <strong>Infants of diabetic mothers</strong>, especially those with <strong>poor glycemic control</strong>, are at an <strong>increased risk </strong>for this condition, as <strong>maternal hyperglycemia </strong>can <strong>delay fetal lung maturity</strong>. The <strong>high levels of insulin </strong>in these <strong>infants</strong>, a response to <strong>maternal hyperglycemia</strong>, can further <strong>inhibit surfactant production</strong>, exacerbating the risk of respiratory distress syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- Nelson 21<sup>st</sup> Edition page 3997</span></strong></span></span></p>",
      "correct_choice_id": 60586,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15157,
      "choices": [
        {
          "id": 60588,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total protein, serum albumin, and liver transaminases</span></span></p>"
        },
        {
          "id": 60589,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total and direct bilirubin, liver transaminases, and a hepatitis panel</span></span></p>"
        },
        {
          "id": 60590,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total bilirubin and a hematocrit</span></span></p>"
        },
        {
          "id": 60591,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct comb test and a complete blood count</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A term infant, born to a mother with pregestational diabetes and weighing 4530 g, initially presents with hypoglycemia, which resolves after feeding. The infant&#39;s size is noted to be large, but otherwise, the physical examination is unremarkable. Approximately 48 hours post-birth, the infant develops mild jaundice, though vital signs remain stable, and feeding is unaffected.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Considering the infant&#39;s background and current presentation of mild jaundice 48 hours after birth, which serum laboratory tests would be most pertinent to evaluate the cause of this infant&#39;s jaundice?</span></span></span></p>",
      "unique_key": "Q8500572",
      "question_audio": null,
      "question_video": null,
      "map_id": 32630,
      "difficulty_level": "difficult",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Total bilirubin and a hematocrit</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C: Total bilirubin and a hematocrit</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Infants born </strong>to <strong>mothers with poorly controlled diabetes </strong>are at <strong>risk for jaundice </strong>due to <strong>high haem turnover secondary to ineffective erythropoiesis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This <strong>baby </strong>most likely has <strong>hyperbilirubinemia secondary </strong>to <strong>liver </strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>immaturity</strong>, possibly <strong>complicated by polycythemia</strong>. He should have a <strong>high level of unconjugated bilirubin </strong>and, in the <strong>absence of intrahepatic disease</strong>, a <strong>normal conjugated </strong>(or direct) <strong>portion</strong>. His hematocrit will also be raised in case of polycythemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Total protein</strong>, <strong>serum albumin</strong>, and <strong>liver transaminases </strong>can be done, but to rule out jaundice, bilirubin levels must be evaluated.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> to r<strong>ule out the polycythemia</strong>, <strong>Hematocrit </strong>must be <strong>added to the panel</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A <strong>direct Coombs test </strong>and a <strong>complete blood count </strong>could be useful if there were <strong>evidence of hemolytic disease </strong>of the <strong>newborn </strong>due to <strong>blood group incompatibility </strong>or other causes of immune-mediated hemolysis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a <strong>term infant presenting with jaundice </strong>within the <strong>first week of life</strong>, the most important <strong>initial tests to evaluate the cause of jaundice </strong>are <strong>total bilirubin </strong>and <strong>hematocrit</strong>. <strong>Total bilirubin </strong>will <strong>help differentiate between unconjugated </strong>(indirect) and <strong>conjugated </strong>(direct) <strong>hyperbilirubinemia</strong>, guiding further <strong>diagnostic </strong>and <strong>management steps</strong>. A <strong>hematocrit </strong>is essential to <strong>assess for hemolysis</strong>, which can be a significant <strong>contributor to neonatal jaundice</strong>, especially in <strong>infants of diabetic mothers </strong>who are at <strong>risk for polycythemia </strong>due to <strong>intrauterine hypoxia</strong>. <strong>Polycythemia </strong>can <strong>lead to increased breakdown of red blood cells</strong>, contributing to the development of <strong>jaundice.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>-</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>OP Ghai 9<sup>th</sup> Edition Page No- 130 and 168.</strong></span></span></span></p>",
      "correct_choice_id": 60590,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}